Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy.
about
Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy.Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.Facioscapulohumeral Muscular Dystrophy.
P2860
Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Drosophila as a starting point ...... e Duchenne Muscular Dystrophy.
@en
type
label
Drosophila as a starting point ...... e Duchenne Muscular Dystrophy.
@en
prefLabel
Drosophila as a starting point ...... e Duchenne Muscular Dystrophy.
@en
P2860
P356
P1476
Drosophila as a starting point ...... e Duchenne Muscular Dystrophy.
@en
P2093
Hannele Ruohola-Baker
Mario Pantoja
P2860
P304
P356
10.4161/RDIS.24995
P577
2013-05-10T00:00:00Z